All Stories

  1. A brief summary of ICER's review of 2 drugs for the treatment of amyloidosis
  2. A framework for developing RWE to inform drug coverage decisions
  3. Opportunities and challenges of Real world evidence
  4. How will we fit gene therapies into the US healthcare system?
  5. Indication-specific pricing of pharmaceuticals in the US healthcare system